Interleukin-34, or IL-34 is a newly discovered interleukin. It was found in a massive screen of secreted proteins by Lin et al. at Five Prime Therapeutics, a company based on the Mission Bay campus of UCSF. IL-34 increases monocyte viablity and acts through its receptor colony-stimulating factor 1. The protein is 39kD in size and forms homodimers.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.